We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Irritated that a previous request for information on Medicare cost estimates has not been answered, several House members yesterday fired off another letter to HHS Secretary Tommy Thompson and invoked the little-known "Seven-Member Rule," demanding that the secretary supply the information by March 15.
Senate supporters of the reimportation of prescription drugs quietly introduced a bill last week that would allow imports from 25 industrialized countries, effectively bypassing a certain committee roadblock in favor of what they consider better odds of passage on the Senate floor.
HHS is going to form a congressionally mandated Drug Importation Task Force to study issues relating to the reimportation of drugs and release a report by December, the department said this week.
A bill pending in the House is intended to fix a patent law problem that has had a chilling effect on collaborative research between industry and universities, but the legislation could produce some unintended problems of its own, according to the Biotechnology Industry Organization (BIO).
A congressional investigation into consulting arrangements and other undisclosed financial relationships between drugmakers and staff at the National Institutes of Health (NIH) has resulted in a demand for more information about a loophole that has allowed institute directors and other top officials to escape disclosure requirements.
The General Accounting Office (GAO) intends to issue its opinion on allegations the Bush administration violated the law by misusing taxpayer money in its advertising campaign for the new Medicare law around the end of March, a GAO spokesperson said last week.
The General Accounting Office (GAO) expects at the end of March to issue its opinion on allegations the Bush administration violated the law by misusing taxpayer money in its advertising campaign for the new Medicare law, a GAO spokesperson said yesterday.
New White House estimates on the cost of the Medicare prescription drug plan could net manufacturers an additional $49 billion in profits, according to congressional Democrats who have demanded that price control mechanisms be added to the benefit program.
The FDA is changing the file-type it accepts for changes to drug labeling from portable document format (PDF) to structured product labeling (SPL) format in order to meet electronic prescribing and health record mandates in the Medicare prescription drug law, the agency said yesterday.
The press secretary for Republican Rep. Billy Tauzin reacted with scorn to a public advocacy group’s request that the Louisiana congressman be investigated for ethics violations in light of reports that he has been offered a job by a drug industry trade association.